Date of Presentation
5-2-2024 12:00 AM
College
Rowan-Virtua School of Osteopathic Medicine
Poster Abstract
Schizophrenia is a complex mental illness with neurobiological underpinnings and misconceptions about violence. Schizophrenia is associated with high levels of creativity and structural traits like fewer D2 receptors. Patients face reduced life expectancy due to cardiovascular diseases and cope through smoking and sedentariness. Treatment involves pharmacological antipsychotics like olanzapine and nonpharmacological approaches. Olanzapine works by antagonizing D2 receptors but has side effects like weight gain and diabetes risk. fMRI is used to study treatment mechanisms and predict response, but research on olanzapine's brain network effects is limited.
Keywords
Schizophrenia, mental illness, olanzapine, fMRI, antipsychotic, clinical management, Functional Magnetic Resonance Imaging
Disciplines
Health and Medical Administration | Medicine and Health Sciences | Mental Disorders | Other Analytical, Diagnostic and Therapeutic Techniques and Equipment | Pharmaceutical Preparations | Psychiatric and Mental Health | Psychiatry | Radiology | Therapeutics
Document Type
Poster
DOI
10.31986/issn.2689-0690_rdw.stratford_research_day.113_2024
Included in
Health and Medical Administration Commons, Mental Disorders Commons, Other Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons, Pharmaceutical Preparations Commons, Psychiatric and Mental Health Commons, Psychiatry Commons, Radiology Commons, Therapeutics Commons
Using fMRI to Assess Effectiveness of Olanzapine Treatment for Schizophrenia
Schizophrenia is a complex mental illness with neurobiological underpinnings and misconceptions about violence. Schizophrenia is associated with high levels of creativity and structural traits like fewer D2 receptors. Patients face reduced life expectancy due to cardiovascular diseases and cope through smoking and sedentariness. Treatment involves pharmacological antipsychotics like olanzapine and nonpharmacological approaches. Olanzapine works by antagonizing D2 receptors but has side effects like weight gain and diabetes risk. fMRI is used to study treatment mechanisms and predict response, but research on olanzapine's brain network effects is limited.